Insertional protein engineering for analytical molecular sensing

Microbial Cell Factories

Volumn 5, Issue , 2006, Pages

  Ferraz, Rosa María ^a,b   Vera, Andrea ^a   Arís, Anna ^a   Villaverde, Antonio ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BETA LACTAMASE INHIBITOR; ESTROGEN; LIGAND; PROTEIN; TACROLIMUS;

ALLOSTERISM; BINDING SITE; BIOSENSOR; CONFORMATIONAL TRANSITION; DRUG SCREENING; GENE INSERTION; GENETIC PROCEDURES; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN ENGINEERING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ARTICLE;

EID: 33646590245     PISSN: 14752859     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-5-15     Document Type: Review

References (61)

1. Thevenot DR, Toth K, Durst RA, Wilson GS: Electrochemical biosensors: recommended definitions and classification. Biosens Bioelectron 2001, 16:121-131.
2. Rich RL, Myszka DG: Survey of the year 2004 commercial optical biosensor literature. J Mol Recognit 2005, 18:431-478.
3. Cooper MA: Biosensor profiling of molecular interactions in pharmacology. Curr Opin Pharmacol 2003, 3:557-562.
4. Piehler J: New methodologies for measuring protein interactions in vivo and in vitro. Curr Opin Struct Biol 2005, 15:4-14.
5. Toby GG, Golemis EA: Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions. Methods 2001, 24:201-217.
6. Yan Y, Marriott G: Analysis of protein interactions using fluorescence technologies. Curr Opin Chem Biol 2003, 7:635-640.
7. Obrdlik P, El Bakkoury M, Hamacher T, Cappellaro C, Vilarino C, Fleischer C, Ellerbrok H, Kamuzinzi R, Ledent V, Blaudez D, Sanders D, Revuelta JL, Boles E, Andre B, Frommer WB: K+ channel interactions detected by a genetic system optimized for systematic studies of membrane protein interactions. Proc Natl Acad Sci U S A 2004, 101:12242-12247.
8. Doi N, Yanagawa H: Insertional gene fusion technology. FEBS Lett 1999, 457:1-4.
9. Ostermeier M: Engineering allosteric protein switches by domain insertion. Protein Eng Des Sel 2005, 18:359-364.
10. Legendre D, Soumillion P, Fastrez J: Engineering a regulatable enzyme for homogeneous immunoassays. Nat Biotechnol 1999, 17:67-72.
11. Guntas G, Ostermeier M: Creation of an allosteric enzyme by domain insertion. J Mol Biol 2004, 336:263-273.
12. Feliu JX, Villaverde A: Engineering of solvent-exposed loops in Escherichia coli beta-galactosidase. FEBS Lett 1998, 434:23-27.
13. Hiraga K, Yamagishi A. Oshima T: Mapping of unit boundaries of a protein: exhaustive search for permissive sites for duplication by complementation analysis of random fragment libraries of tryptophan synthase alpha subunit. J Mol Biol 2004, 335:1093-1104.
14. Charbit A, Ronco J, Michel V, Werts C, Hofnung M: Permissive sites and topology of an outer membrane protein with a reporter epitope. J Bacteriol 1991, 173:262-275.
15. Martineau P, Guillet JG, Leclerc C, Hofnung M: Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. Gene 1992, 113:35-46.
16. Manoil C, Bailey J: A simple screen for permissive sites in proteins: analysis of Escherichia coli lac permease. J Mol Biol 1997, 267:250-263.
17. Coeffier E, Clement JM, Cussac V, Khodaei-Boorane N, Jehanno M, Rojas M, Dridi A, Latour M, El Habib R, Barre-Sinoussi F, Hofnung M, Leclerc C: Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MaIE protein. Vaccine 2000, 19:684-693.
18. Aris A, Villaverde A: Modular protein engineering for non-viral gene therapy. Trends Biotechnol 2004, 22:371-377.
19. Bckstrom M, Holmgren J, Schodel F, Lebens M: Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Gene 1995, 165:163-171.
20. Ehrmann M, Clausen T: Proteolysis as a regulatory mechanism. Annu Rev Genet 2004, 38:709-724.
21. Goulet B, Nepveu A: Complete and limited proteolysis in cell cycle progression. Cell Cycle 2004, 3:986-989.
22. Hilt W: Targets of programmed destruction: a primer to regulatory proteolysis in yeast. Cell Mol Life Sci 2004, 61:1615-1632.
23. Benito A, Mateu MG, Villaverde A: Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on beta-galactosidase surface. Biotechnology (N Y) 1995, 13:801-804.
24. Chiang CF, Okou DT, Griffin TB, Verret CR, Williams MN: Green fluorescent protein rendered susceptible to proteolysis: positions for protease-sensitive insertions. Arch Biochem Biophys 2001, 394:229-235.
25. Baum EZ, Bebernitz GA, Gluzman Y: beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease. Proc Natl Acad Sci U S A 1990, 87:10023-10027.
26. Vera A, Aris A, Daura X, Martinez MA, Villaverde A: Engineering the E. coli beta-galactosidase for the screening of antiviral protease inhibitors. Biochem Biophys Res Commun 2005, 329:453-456.
27. Pufall MA, Graves BJ: Autoinhibitory domains: modular effectors of cellular regulation. Annu Rev Cell Dev Biol 2002, 18:421-462.
28. Geddie ML, O'Loughlin TL, Woods KK, Matsumura I: Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensors. J Biol Chem 2005, 280:35641-35646.
29. Kohl T, Heinze KG, Kuhlemann R, Koltermann A, Schwille P: A protease assay for two-photon crosscorrelation and FRET analysis based solely on fluorescent proteins. Proc Natl Acad Sci U S A 2002, 99:12161-12166.
30. Zhang B: Design of FRET-based GFP probes for detection of protease inhibitors. Biochem Biophys Res Commun 2004, 323:674-678.
31. Nagai T, Miyawaki A: A high-throughput method for development of FRET-based indicators for proteolysis. Biochem Biophys Res Commun 2004, 319:72-77.
32. Goh YY, Frecer V, Ho B, Ding JL: Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng 2002, 15:493-502.
33. Martinez MA, Cabana M, Parera M, Gutierrez A, Este JA, Clotet B: A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type I protease. Antimicrob Agents Chemother 2000, 44:1132-1139.
34. Martinez MA, Clotet B: Genetic screen for monitoring hepatitis C virus NS3 serine protease activity. Antimicrob Agents Chemother 2003, 47:1760-1765.
35. Parera M, Clotet B, Martinez MA: Genetic screen for monitoring severe acute respiratory syndrome coronavirus 3C-like protease. J Virol 2004, 78:14057-14061.
36. Cabana M, Fernandez G, Parera M, Clotet B, Martinez MA: Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions. Virology 2002, 300:71-78.
37. Villaverde A: Allosteric enzymes as biosensors for molecular diagnosis. FEBS Lett 2003, 554:169-172.
38. Benito A, Villaverde A: Insertion of a 27 amino acid viral peptide in different zones of Escherichia coli beta-galactosidase: effects on the enzyme activity. FEMS Microbiol Lett 1994, 123:107-112.
39. Benito A, Feliu JX, Villaverde A: Beta-galactosidase enzymatic activity as a molecular probe to detect specific antibodies. J Biol Chem 1996, 271:21251-21256.
40. Ferrer-Miralles N, Feliu JX, Vandevuer S, Muller A, Cabrera-Crespo J, Ortmans I, Hoffmann F, Cazorla D, Rinas U, Prevost M, Villaverde A: Engineering regulable, Escherichia coli beta-galactosidases as biosensors for anti-HIV antibody detection in human sera. J Biol Chem 2001, 276:40087-40095.
41. Brennan CA, Christianson K, La Fleur MA, Mandecki W: A molecular sensor system based on genetically engineered alkaline phosphatase. Proc Natl Acad Sci U S A 1995, 92:5783-5787.
42. Doi N, Yanagawa H: Design of generic biosensors based on green fluorescent proteins with allosteric sites by directed evolution. FEBS Lett 1999, 453:305-307.
43. Doi N, Yanagawa H: Evolutionary design of generic green fluorescent protein biosensors. Methods Mol Biol 2002, 183:49-55.
44. Feliu JX, Ferrer-Miralles N, Blanco E, Cazorla D, Sobrino, F, Villaverde A: Enhanced response to antibody binding in engineered beta-galactosidase enzymatic sensors. Biochim Biophys Acta 2002, 1596:212-224.
45. Alcala P, Feliu JX, Aris A, Villaverde A: Efficient accommodation of recombinant, foot-and-mouth disease virus RGD peptides to cell-surface integrins. Biochem Biophys Res Commun 2001, 285:201-206.
46. Feliu JX, Benito A, Oliva B, Aviles FX, Villaverde A: Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding. J Mol Biol 1998, 283:331-338.
47. Brennan C, Christianson K, Surowy T, Mandecki W. Modulation of enzyme activity by antibody binding to an alkaline phosphatase-epitope hybrid protein. Protein Eng 1994, 7:509-514.
48. Ferrer-Miralles N, Feliu JX, Villaverde A: Molecular mechanisms for antibody-mediated modulation of peptide-displaying enzyme sensors. Biochem Biophys Res Commun 2000, 275:360-364.
49. Cazorla D, Feliu JX, Ferrer-Miralles N, Villaverde A: Tailoring molecular sensing for peptide displaying engineered enzymes. Biotechnology Letters 2002, 24:467-477.
50. Ferraz RM, Aris A, Villaverde A: Profiling the allosteric response of an engineered beta-galactosidase to its effector, anti-HIV antibody. Biochem Biophys Res Commun 2004, 314:854-860.
51. Ferraz RM, Aris A, Villaverde A: Enhanced molecular recognition signal in allosteric biosensing by proper substrate selection. Biotechnol Bioeng 2006, 94(1):193-9.
52. Ferraz RM, Aris A, Martinez MA, Villaverde A: High-throughput, functional screening of the anti-HIV-1 humoral response by an enzymatic nanosensor. Mol Immunol 2006, 43(13):2119-23.
53. de Rosny E, Vassell R, Jiang S, Kunert R, Weiss CD: Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes. J Virol 2004, 78:2627-2631.
54. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire F, Wyatt R. Sodroski J, Hendrickson WA, Arthos J: HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002, 420:678-682.
55. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM: Antibody neutralization and escape by HIV-1. Nature 2003, 422:307-312.
56. Kohn JE, Plaxco KW: Engineering a signal transduction mechanism for protein-based biosensors. Proc Natl Acad Sci U S A 2005, 102:10841-10845.
57. Tucker CL, Fields S: A yeast sensor of ligand binding. Nat Biotechnol 2001, 19:1042-1046.
58. Vidan S, Snyder M: Making drug addicts out of yeast Nat Biotechnol 2001, 19:1022-1023.
59. Agarwal PK: Enzymes: An integrated view of structure, dynamics and function. Microb Cell Fact 2006, 5:2.
60. Feliu JX, Ramirez E, Villaverde A: Distinct mechanisms of antibody-mediated enzymatic reactivation in beta-galactosidase molecular sensors. FEBS Lett 1998, 438:267-271.
61. Marvin JS, Hellinga HW: Conversion of a maltose receptor into a zinc biosensor by computational design. Proc Natl Acad Sci U S A 2001, 98:4955-4960.